HEALTHPEAK PROPERTIES, INC. (DOC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5B 3B 4.5B Q3 '16: 2.1B Q4 '16: 2.1B Q1 '17: 2.1B Q2 '17: 2B Q3 '17: 1.9B Q4 '17: 1.8B Q1 '18: 1.8B Q2 '18: 1.8B Q3 '18: 1.8B Q4 '18: 1.8B Q1 '19: 1.8B Q2 '19: 1.8B Q3 '19: 1.9B Q4 '19: 1.8B Q1 '20: 1.7B Q2 '20: 1.6B Q3 '20: 1.5B Q4 '20: 1.6B Q1 '21: 1.7B Q2 '21: 1.8B Q3 '21: 1.8B Q4 '21: 1.9B Q1 '22: 1.9B Q2 '22: 2B Q3 '22: 2B Q4 '22: 2.1B Q1 '23: 2.1B Q2 '23: 2.1B Q3 '23: 2.2B Q4 '23: 2.2B Q1 '24: 2.3B Q2 '24: 2.4B Q3 '24: 2.6B Q4 '24: 2.7B Q1 '25: 2.8B Q2 '25: 2.8B Q3 '25: 2.8B Q4 '25: 2.8B Q1 '26: 2.9B Q2 '26: 2.9B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

0 600M 1.2B 1.8B Q4 '17: 1.2B Q1 '18: 1.2B Q2 '18: 1.1B Q3 '18: 1.1B Q4 '20: 862.3M Q1 '21: 992.2M Q2 '21: 1B Q3 '21: 1.1B Q4 '21: 1.1B Q1 '22: 1.1B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '22: 1.2B Q1 '23: 1.2B Q2 '23: 1.2B Q3 '23: 1.3B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.4B Q3 '24: 1.5B Q4 '24: 1.6B Q1 '25: 1.7B Q2 '25: 1.7B Q3 '25: 1.7B Q2 '18 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-400M 0 400M 800M 1.2B Q3 '16: -29.8M Q4 '16: 627.7M Q1 '17: 972.8M Q2 '17: 690.4M Q3 '17: 531.5M Q4 '17: 414.2M Q1 '18: -6.7M Q2 '18: 63.8M Q3 '18: 170.8M Q4 '18: 1.1B Q1 '19: 1.1B Q2 '19: 978.8M Q3 '19: 833.6M Q4 '19: 45.5M Q1 '20: 263.1M Q2 '20: 328.2M Q3 '20: 310.7M Q4 '20: 413.6M Q1 '21: 280.3M Q2 '21: 505M Q3 '21: 623.2M Q4 '21: 505.5M Q1 '22: 431.4M Q2 '22: 223.4M Q3 '22: 522.7M Q4 '22: 500.4M Q1 '23: 547.8M Q2 '23: 531.3M Q3 '23: 241.6M Q4 '23: 306M Q1 '24: 193.7M Q2 '24: 287.9M Q3 '24: 309.5M Q4 '24: 243.1M Q1 '25: 279.3M Q2 '25: 164.9M Q3 '25: -38.1M Q4 '25: 71.3M Q1 '26: 222.2M Q2 '26: 243.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

0 400M 800M 1.2B Q4 '17: 666.3M Q1 '18: 679.7M Q2 '18: 700.4M Q3 '18: 726.3M Q4 '20: 782.5M Q1 '21: 726.9M Q2 '21: 739.2M Q3 '21: 758.2M Q4 '21: 773.3M Q1 '22: 798.8M Q2 '22: 823.7M Q3 '22: 841.7M Q4 '22: 863M Q1 '23: 878.8M Q2 '23: 885.6M Q3 '23: 898.2M Q4 '23: 902.1M Q1 '24: 922.7M Q2 '24: 974.7M Q3 '24: 1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.1B Q2 '18 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Operating Cash Flow TTM

0 500M 1B 1.5B Q3 '16: 1.4B Q4 '16: 1.2B Q1 '17: 1.1B Q2 '17: 978.8M Q3 '17: 853.4M Q4 '17: 847M Q1 '18: 850.1M Q2 '18: 855.1M Q3 '18: 842.1M Q4 '18: 848.7M Q1 '19: 811.1M Q2 '19: 789.6M Q3 '19: 844.4M Q4 '19: 846.1M Q1 '20: 782.5M Q2 '20: 785.3M Q3 '20: 757.2M Q4 '20: 758.4M Q1 '21: 786.1M Q2 '21: 798.2M Q3 '21: 790M Q4 '21: 795.2M Q1 '22: 866.7M Q2 '22: 885.3M Q3 '22: 917.2M Q4 '22: 900.3M Q1 '23: 880M Q2 '23: 922.3M Q3 '23: 931.9M Q4 '23: 956.2M Q1 '24: 934.9M Q2 '24: 953.3M Q3 '24: 1B Q4 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.3B Q1 '26: 1.2B Q2 '26: 1.2B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

0 350M 700M 1.1B Q4 '14: 975.6M Q1 '15: 942.8M Q2 '15: 923.6M Q3 '15: 869M Q4 '15: 837.4M Q1 '16: 831.2M Q2 '16: 827.2M Q3 '16: 882.7M Q4 '16: 755.2M Q4 '14 Q2 '15 Q4 '15 Q2 '16 Q4 '16

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 250M 500M 750M Q2 '13: 455.4M Q3 '13: 456.1M Q1 '14: 457.7M Q2 '14: 458.6M Q3 '14: 459.1M Q1 '15: 460.9M Q2 '15: 462.1M Q3 '15: 463.6M Q1 '16: 466.3M Q2 '16: 471.4M Q3 '16: 467.8M Q1 '17: 475.2M Q2 '17: 468.8M Q3 '17: 469M Q1 '18: 469.7M Q2 '18: 469.9M Q3 '18: 470.1M Q1 '19: 479.1M Q2 '19: 478.7M Q3 '19: 491.2M Q1 '20: 515M Q2 '20: 538.5M Q3 '20: 538.3M Q1 '21: 538.7M Q2 '21: 544.7M Q3 '21: 539.4M Q1 '22: 539.6M Q2 '22: 539.8M Q3 '22: 546M Q1 '23: 547.1M Q2 '23: 547.3M Q3 '23: 547.3M Q1 '24: 601.2M Q2 '24: 703.3M Q3 '24: 700.1M Q1 '25: 699.1M Q2 '25: 695.2M Q3 '25: 694.9M Q1 '26: 695.2M Q2 '26: 689.9M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.80 0.00 0.80 1.60 2.40 Q3 '16: -0.08 Q4 '16: 1.33 Q1 '17: 2.05 Q2 '17: 1.45 Q3 '17: 1.11 Q4 '17: 0.86 Q1 '18: -0.03 Q2 '18: 0.12 Q3 '18: 0.35 Q4 '18: 2.21 Q1 '19: 2.26 Q2 '19: 2.04 Q3 '19: 1.74 Q4 '19: 0.10 Q1 '20: 0.51 Q2 '20: 0.63 Q3 '20: 0.60 Q4 '20: 0.78 Q1 '21: 0.51 Q2 '21: 0.93 Q3 '21: 1.15 Q4 '21: 0.93 Q1 '22: 0.79 Q2 '22: 0.41 Q3 '22: 0.96 Q4 '22: 0.92 Q1 '23: 1.01 Q2 '23: 0.97 Q3 '23: 0.44 Q4 '23: 0.56 Q1 '24: 0.35 Q2 '24: 0.47 Q3 '24: 0.47 Q4 '24: 0.34 Q1 '25: 0.39 Q2 '25: 0.23 Q3 '25: -0.06 Q4 '25: 0.10 Q1 '26: 0.32 Q2 '26: 0.35 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.